New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Proceedings of the 1st biannual bridging the gaps in lung cancer conference.
Proceedings of the 1st biannual bridging the gaps in lung cancer conference. The oncologist Florez, N., Patel, S. P., Wakelee, H., Bazhenova, L., Massarelli, E., Salgia, R., Stiles, B., Peters, S., Malhotra, J., Gadgeel, S. M., Nieva, J. J., Afkhami, M., Hirsch, F. R., Gubens, M., Cascone, T., Levy, B., Sabari, J., Husain, H., Ma, P. C., Backhus, L. M., Iyengar, P., Lee, P., Miller, R., Sands, J., Kim, E. 2024Abstract
Lung cancer is the leading cause of cancer death in the US and globally. The mortality from lung cancer has been declining, due to a reduction in incidence and advances in treatment. Although recent success in developing targeted and immunotherapies for lung cancer has benefitted patients, it has also expanded the complexity of potential treatment options for health care providers. To aid in reducing such complexity, experts in oncology convened a conference (Bridging the Gaps in Lung Cancer) to identify current knowledge gaps and controversies in the diagnosis, treatment, and outcomes of various lung cancer scenarios, as described here. Such scenarios relate to biomarkers and testing in lung cancer, small cell lung cancer, EGFR mutations and targeted therapy in non-small cell lung cancer (NSCLC), early-stage NSCLC, KRAS/BRAF/MET and other genomic alterations in NSCLC, and immunotherapy in advanced NSCLC.
View details for DOI 10.1093/oncolo/oyae228
View details for PubMedID 39237103